BeStock  
Stocks › Biotechnology › AGIO

Agios Pharmaceuticals AGIO

US equityMarket cap rank #2807Biotechnology
$27.60 −$1.16 (-4.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.60 0.00%
Open$28.01
Prev close$28.76
Day range$27.43 – $29.14
Volume776.2K
Market cap$1.65B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±4.1%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+13.1%
Worst reaction-9.9%

Stock move on the day after each report

+3.5%2023/Q4+2.7%2024/Q1-4.1%2024/Q2-4.0%2024/Q3+1.5%2024/Q4+4.2%2025/Q1-0.9%2025/Q2+2.9%2025/Q3+1.3%2025/Q4+13.1%2026/Q1-6.5%2026/Q2-9.9%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026None±9.0%-9.91%Bigger than priced
2026/Q230 Jul 2026Pre Market±9.5%-6.46%Within range
2026/Q129 Apr 2026Pre Market±8.5%+13.10%Bigger than priced
2025/Q412 Feb 2026Pre Market±12.5%+1.30%Within range
2025/Q330 Oct 2025Pre Market±16.6%+2.91%Within range
2025/Q231 Jul 2025Pre Market±11.4%-0.85%Within range
2025/Q11 May 2025Pre Market±21.6%+4.21%Within range
2024/Q413 Feb 2025None±8.3%+1.49%Within range
2024/Q331 Oct 2024Pre Market±15.7%-4.04%Within range
2024/Q21 Aug 2024Pre Market±13.5%-4.09%Within range
2024/Q12 May 2024Pre Market±13.7%+2.73%Within range
2023/Q415 Feb 2024Pre Market±9.0%+3.47%Within range
2023/Q32 Nov 2023Pre Market±9.8%-1.41%Within range
2023/Q23 Aug 2023None±15.2%-0.15%Within range
2023/Q14 May 2023Pre Market±10.6%+7.65%Within range
2022/Q423 Feb 2023Pre Market±21.9%-1.73%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$55.39M+330.0% YoY
Operating profit-$77.16M+34.0% YoY
Net profit-$65.05M+37.1% YoY
Diluted EPS-$1.09+38.8% YoY
Free cash flow-$60.42M+32.6% YoY
Operating cash flow-$59.24M

Revenue, last 8 quarters

$10.7MDec '24$8.7MMar '25$12.5MJun '25$12.9MSep '25$20.0MDec '25$20.7MMar '26$44.7MJun '26$55.4MSep '26

Net profit, last 8 quarters

$-96.5MDec '24$-89.3MMar '25$-112.0MJun '25$-103.4MSep '25$-108.0MDec '25$-99.1MMar '26$-100.7MJun '26$-65.0MSep '26

Profitability & balance sheet

Gross margin93.8%
Operating margin-297.7%
Net margin-264.8%
Return on equity-32.9%
Return on assets-30.4%
Return on invested capital-35.5%
Current ratio9.69
Liabilities / assets8.0%
Cash & investments$630.01M
Total debt$6.88M
Net cash (debt)$623.13M

Discussion

No comments yet — be the first to weigh in on AGIO.

Sign in to join the discussion.

Scroll to Top